Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04408118
Title First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin) in mTNBC (ATRACTIB)
Acronym ATRACTIB
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | GBR | FRA | ESP | DEU

Facility Status City State Zip Country Details
Hopital Europeen Georges Pompidou Paris France Details
Klinikum Dessau (MVZ) - Frauenheilkunde Dessau Germany Details
University Hospital Essen Essen Germany Details
Universitätsklinikum Mannheim Mannheim Germany Details
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Naples Italy Details
Hospital de Dénia-MarinaSalud Dénia Alicante Spain Details
Hospital Universitario La Ribera Alzira Spain Details
Hospital de Sant Joan Despí - Moises Broggi Barcelona Spain Details
Hospital Universitari Dexeus Barcelona Spain Details
Hospital Universitario Clínico San Cecilio Granada Spain Details
Hospital Universitario Insular de Gran Canaria Las Palmas De Gran Canaria Spain Details
Hospital Universitari Arnau de Vilanova Lleida Spain Details
Hospital Clínico San Carlos Madrid Spain Details
Hospital Ruber Juan Bravo Madrid Spain Details
Hospital Universitario Ramón y Cajal Madrid Spain Details
MD Anderson Cancer Center Madrid Spain Details
Complejo Hospitalario de Navarra Pamplona Spain Details
Hospital Universitari Sant Joan de Reus Reus Spain Details
Hospital Universitario San Juan de Alicante San Juan De Alicante Spain Details
Hospital Universitario Virgen del Rocío Sevilla Spain Details
Hospital Quirón Valencia Valencia Spain Details
Hospital Universitario Miguel Servet Zaragoza Spain Details
Barts Health NHS Trust London United Kingdom Details
Royal Cornwall Hospitals Nhs Trust Truro United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field